NKAIN4 activators comprise a unique chemical class that centers on modulating the function of the NKAIN4 protein by influencing the Na+/K+ ATPase activity and associated ion channels. These activators encompass a variety of compounds, including cardiac glycosides, ionophores, alkaloids, and specific inhibitors of ion transport mechanisms. The primary mode of action for these chemicals involves altering the intracellular ion concentrations, which can have cascading effects on cellular processes. By binding to the extracellular domain of Na+/K+ ATPase, certain members of this class can change the ionic gradients across the cell membrane. This alteration in ion homeostasis can lead to changes in cellular activities, including those regulated by NKAIN4.
The interaction between these chemicals and NKAIN4 is mediated through the modulation of the cellular environment where NKAIN4 functions. For instance, by influencing the expression and functionality of Na+/K+ ATPase, some activators can shift the balance of ion transport, possibly leading to the activation of NKAIN4. Others operate by disrupting the usual ion transport pathways, such as converting the Na+/K+ ATPase from a pump into an open ion channel or by inhibiting other ion transporters like the vacuolar H+-ATPase, which can result in changes that stimulate NKAIN4 activity. The diversity of this chemical class is marked by their varying structures and origins, yet their unifying feature is their capacity to modulate ion gradients and transport, which serves as a principal route to engage and modulate the activity of NKAIN4 within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $140.00 $680.00 | ||
12β-Hydroxydigitoxin, another cardiac glycoside, inhibits Na+/K+ ATPase, which could possibly activate NKAIN4 by affecting associated pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Monensin is an ionophore that disrupts Na+ gradients; its action on Na+/K+ ATPase could possibly activate NKAIN4. | ||||||
Veratridine | 71-62-5 | sc-201075B sc-201075 sc-201075C sc-201075A | 5 mg 10 mg 25 mg 50 mg | $80.00 $102.00 $197.00 $372.00 | 3 | |
Veratridine is an alkaloid that modulates sodium channels, which could possibly activate NKAIN4 by increasing Na+/K+ ATPase workload. | ||||||
Bufalin | 465-21-4 | sc-200136 sc-200136A sc-200136B sc-200136C | 10 mg 25 mg 50 mg 100 mg | $97.00 $200.00 $334.00 $533.00 | 5 | |
Bufalin, like ouabain, inhibits Na+/K+ ATPase, which could possibly activate NKAIN4 by influencing related processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 is a vacuolar H+-ATPase inhibitor that could possibly activate NKAIN4 by altering cellular ion homeostasis and affecting Na+/K+ ATPase. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium ions can affect sodium transport and signaling pathways, which could possibly activate NKAIN4 by influencing Na+/K+ ATPase activity. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $107.00 $157.00 $449.00 | 6 | |
Nitrendipine, a calcium channel blocker, could possibly activate NKAIN4 by altering cellular calcium levels which affect Na+/K+ ATPase. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $102.00 | 20 | |
Phenamil, an amiloride analog, inhibits Na+ channels and could possibly activate NKAIN4 by affecting Na+/K+ ATPase activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A is an immunosuppressant that could possibly activate NKAIN4 by impacting ion transport and signaling, potentially affecting Na+/K+ ATPase. | ||||||